London
· Delayed Price · Currency is GBP · Price in EUR Neurones Statistics
Total Valuation
Neurones has a market cap or net worth of GBP 890.94 million. The enterprise value is 745.30 million.
| Market Cap | 890.94M |
| Enterprise Value | 745.30M |
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | Jun 12, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.80M |
Valuation Ratios
The trailing PE ratio is 21.67.
| PE Ratio | 21.67 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 20.48.
| EV / Earnings | 18.13 |
| EV / Sales | 1.14 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 11.98 |
| EV / FCF | 20.48 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.24 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 1.09 |
| Interest Coverage | 48.40 |
Financial Efficiency
Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 10.67%.
| Return on Equity (ROE) | 14.87% |
| Return on Assets (ROA) | 7.06% |
| Return on Capital (ROIC) | 10.67% |
| Revenue Per Employee | 95,925 |
| Profits Per Employee | 6,002 |
| Employee Count | 6,749 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 243.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.69% in the last 52 weeks. The beta is 0.56, so Neurones's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +0.69% |
| 50-Day Moving Average | 44.98 |
| 200-Day Moving Average | 44.60 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 71 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neurones had revenue of GBP 656.99 million and earned 41.11 million in profits. Earnings per share was 1.69.
| Revenue | 656.99M |
| Gross Profit | 310.73M |
| Operating Income | 62.37M |
| Pretax Income | 68.85M |
| Net Income | 41.11M |
| EBITDA | 69.69M |
| EBIT | 62.37M |
| Earnings Per Share (EPS) | 1.69 |
Balance Sheet
The company has 227.31 million in cash and 39.62 million in debt, giving a net cash position of 187.70 million.
| Cash & Cash Equivalents | 227.31M |
| Total Debt | 39.62M |
| Net Cash | 187.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 338.24M |
| Book Value Per Share | 12.22 |
| Working Capital | 256.84M |
Cash Flow
In the last 12 months, operating cash flow was 52.72 million and capital expenditures -16.33 million, giving a free cash flow of 36.38 million.
| Operating Cash Flow | 52.72M |
| Capital Expenditures | -16.33M |
| Free Cash Flow | 36.38M |
| FCF Per Share | n/a |
Margins
Gross margin is 47.30%, with operating and profit margins of 9.49% and 6.26%.
| Gross Margin | 47.30% |
| Operating Margin | 9.49% |
| Pretax Margin | 10.48% |
| Profit Margin | 6.26% |
| EBITDA Margin | 10.61% |
| EBIT Margin | 9.49% |
| FCF Margin | 5.54% |
Dividends & Yields
Neurones does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 7.82% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 60.07% |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | 4.61% |
| FCF Yield | 4.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neurones has an Altman Z-Score of 4.23.
| Altman Z-Score | 4.23 |
| Piotroski F-Score | n/a |